Altimmune (ALT) announced the expansion of its Board of Directors with the appointments of Teri Lawver and Jerry Durso. Lawver is most recently served as Executive Vice President and Chief Commercial Officer at Dexcom (DXCM). Durso most recently served as CEO and a member of the Board of Directors of Intercept (ICPT) Pharmaceuticals.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT: